Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Scientists in Technology “Relay Race” Against Cancer

Published: Monday, May 20, 2013
Last Updated: Monday, May 20, 2013
Bookmark and Share
GE technologies being developed to impact every stage of cancer patient care from screening to treatment and monitoring.

To commemorate National Cancer Research Month, a team of scientists from GE Global Research, the technology development arm of the General Electric Co., are joined together in a technology “relay race” against cancer. They collectively are driving technologies across the entire continuum of cancer care with the end-goal of improving patient outcomes.

The research and development activities of GE scientists are highlighted in a special video that walks through every stage of cancer patient care from screening, diagnosis, biopsy and staging to treatment, monitoring and remission. During the video, Fiona Ginty, a principal scientist at GE Global Research, summed up the multi-disciplinary team effort underway inside GE’s research labs.

Ginty stated, “There are many stages to the patient’s treatment journey. We have amazing teams here; people from all backgrounds, from biology, chemistry, engineering, optical sciences you name it. A team like that is what is needed in order to create new technology and new solutions for patients.”

Cindy Davis, Therapy Platform Leader at GE Global Research, stated, “We have been looking at cancer from a disease perspective rather than a technology perspective and how do we pull in the different technologies that are needed at each different stage of the patient’s journey.”

According to the World Cancer Research Fund, an estimated 21 million cancer cases will occur worldwide in 2013 alone. At each stage of the patient’s journey, GE scientists are developing new technologies to help more patients emerge cancer free.

Screening – Developing a digital mammography system to enable a 3D representation of a woman’s breast to potentially help clinicians detect cancer earlier.

Diagnosis – Work on a new high-risk screening platform using Magnetic Resonance Imaging (MRI), with the goal of providing a more reliable of way of diagnosing women who are at a greater risk of getting cancer early.

Biopsy – Driving advancements in molecular pathology to allow pathologists to see inside a tumor in new ways. GE’s technology is being developed to highlight more than 60 disease markers in a single tissue sample. Standard samples viewed today typically show only one or two markers. These new insights could help determine if a cancer is more or less aggressive and what treatments a patient might respond best to.

Staging – New methods being developed using Positron Emission Technology (PET) imaging to more precisely measure the progress of how a patient is responding to treatment. The goal is to shrink the time it takes to monitor how treatments are going from months to weeks.

Treatment –Exploring ways to bring multiple healthcare technologies together to combat cancer more effectively. GE Global Research has an Interventional & Therapy Lab that is combining X-Ray, Ultrasound, software and analytics and other healthcare technologies to improve how cancer is treated. In addition, GE scientists are developing better tools to support emerging cell therapies being developed and used to treat cancer.

Monitoring – Developing contrast agents for MRI that will allow metabolic activity in the body to be observed in real-time. This could enable doctors to identify the aggressiveness of a tumor and impact the course of treatments.

Remission – Focused on new technologies that can monitor a patient after they have been treated and determine if a cancer has come back much earlier. This could help make the treatment of cancer more manageable.

At the end of the video, Ashwin Wagadarikar, an electrical engineer in the Functional Imaging Lab, concluded, stating, “This race, like any other race, will have a finish line.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Wearable Microscope Can Measure Fluorescent Dyes Through Skin
UCLA research could make monitoring disease biomarkers easier and more cost-effective.
“Sixth Sense” More Than a Feeling
NIH study of rare genetic disorder reveals importance of touch and body awareness.
A Diversity of Genomes
New DNA from understudied groups reveals modern genetic variation, ancient population shifts.
Gene Could Reduce Female Mosquitoes
Virginia Tech researchers have found a gene that can reduce female mosquitoes over many generations.
Improving Crop Efficiency with CRISPR
New study of CRISPR-Cas9 technology from Virginia Tech shows potential to improve crop efficiency.
Examining mtDNA May Help Identify Unknown Ancestry That Influences Breast Cancer Risk
Researchers studying mtDNA in a group of triple negative breast cancer patients found that 13 percent of participants were unaware of ancestry that could influence their risk of cancer.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!